Connection

DAVID BATES to Adverse Drug Reaction Reporting Systems

This is a "connection" page, showing publications DAVID BATES has written about Adverse Drug Reaction Reporting Systems.
  1. Overrides of clinical decision support alerts in primary care clinics. Stud Health Technol Inform. 2013; 192:923.
    View in: PubMed
    Score: 0.404
  2. Understanding responses to a renal dosing decision support system in primary care. Stud Health Technol Inform. 2013; 192:931.
    View in: PubMed
    Score: 0.404
  3. Development of a web-based observational tool for detecting intravenous medication errors with smart infusion pumps. Stud Health Technol Inform. 2013; 192:1102.
    View in: PubMed
    Score: 0.404
  4. Do package inserts reflect symptoms experienced in practice?: assessment using an automated phone pharmacovigilance system with varenicline and zolpidem in a primary care setting. Drug Saf. 2012 Aug 01; 35(8):623-8.
    View in: PubMed
    Score: 0.392
  5. High-priority drug-drug interactions for use in electronic health records. J Am Med Inform Assoc. 2012 Sep-Oct; 19(5):735-43.
    View in: PubMed
    Score: 0.385
  6. Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting. Pharmacoepidemiol Drug Saf. 2010 Dec; 19(12):1211-5.
    View in: PubMed
    Score: 0.350
  7. Participation in an ambulatory e-pharmacovigilance system. Pharmacoepidemiol Drug Saf. 2010 Sep; 19(9):961-9.
    View in: PubMed
    Score: 0.344
  8. Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention. J Gen Intern Med. 2010 Jan; 25(1):31-8.
    View in: PubMed
    Score: 0.325
  9. Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. J Am Geriatr Soc. 2008 Dec; 56(12):2225-33.
    View in: PubMed
    Score: 0.304
  10. Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application. J Am Med Inform Assoc. 2008 Sep-Oct; 15(5):647-53.
    View in: PubMed
    Score: 0.295
  11. Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf. 2007 Sep; 2(3):177-85.
    View in: PubMed
    Score: 0.279
  12. Adverse drug event detection in a community hospital utilising computerised medication and laboratory data. Drug Saf. 2007; 30(9):817-24.
    View in: PubMed
    Score: 0.267
  13. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions. Pharmacoepidemiol Drug Saf. 2005 Nov; 14(11):755-67.
    View in: PubMed
    Score: 0.246
  14. Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc. 2004 Nov-Dec; 11(6):492-8.
    View in: PubMed
    Score: 0.226
  15. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004 Aug; 13(4):306-14.
    View in: PubMed
    Score: 0.225
  16. Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice. Clin Pharmacol Ther. 2004 Jan; 75(1):110-22.
    View in: PubMed
    Score: 0.216
  17. Detecting adverse events using information technology. J Am Med Inform Assoc. 2003 Mar-Apr; 10(2):115-28.
    View in: PubMed
    Score: 0.204
  18. Using information technology to screen for adverse drug events. Am J Health Syst Pharm. 2002 Dec 01; 59(23):2317-9.
    View in: PubMed
    Score: 0.201
  19. Drug complications in outpatients. J Gen Intern Med. 2000 Mar; 15(3):149-54.
    View in: PubMed
    Score: 0.166
  20. Identifying drug safety issues: from research to practice. Int J Qual Health Care. 2000 Feb; 12(1):69-76.
    View in: PubMed
    Score: 0.165
  21. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med. 1999 Nov 22; 159(21):2553-60.
    View in: PubMed
    Score: 0.163
  22. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc. 1998 May-Jun; 5(3):305-14.
    View in: PubMed
    Score: 0.146
  23. High Override Rate for Opioid Drug-allergy Interaction Alerts: Current Trends and Recommendations for Future. Stud Health Technol Inform. 2015; 216:242-6.
    View in: PubMed
    Score: 0.116
  24. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993 Jun; 8(6):289-94.
    View in: PubMed
    Score: 0.104
  25. Clinical prediction rule to identify high-risk inpatients for adverse drug events: the JADE Study. Pharmacoepidemiol Drug Saf. 2012 Nov; 21(11):1221-6.
    View in: PubMed
    Score: 0.098
  26. Preventable adverse drug events and their causes and contributing factors: the analysis of register data. Int J Qual Health Care. 2011 Apr; 23(2):187-97.
    View in: PubMed
    Score: 0.088
  27. Risk factors in preventable adverse drug events in pediatric outpatients. J Pediatr. 2008 Feb; 152(2):225-31.
    View in: PubMed
    Score: 0.071
  28. Adherence to black box warnings for prescription medications in outpatients. Arch Intern Med. 2006 Feb 13; 166(3):338-44.
    View in: PubMed
    Score: 0.063
  29. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005 Jan 24; 165(2):234-40.
    View in: PubMed
    Score: 0.058
  30. Multifaceted approach to reducing preventable adverse drug events. Am J Health Syst Pharm. 2003 Mar 15; 60(6):582-6.
    View in: PubMed
    Score: 0.051
  31. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003 Mar 05; 289(9):1107-16.
    View in: PubMed
    Score: 0.051
  32. Policy and the future of adverse event detection using information technology. J Am Med Inform Assoc. 2003 Mar-Apr; 10(2):226-8.
    View in: PubMed
    Score: 0.051
  33. Information technology and medication safety: what is the benefit? Qual Saf Health Care. 2002 Sep; 11(3):261-5.
    View in: PubMed
    Score: 0.049
  34. Heterogeneity of Drug Allergies and Reaction Lists in Two U.S. Health Care Systems' Electronic Health Records. Appl Clin Inform. 2022 05; 13(3):741-751.
    View in: PubMed
    Score: 0.048
  35. Intelligent Telehealth in Pharmacovigilance: A Future Perspective. Drug Saf. 2022 05; 45(5):449-458.
    View in: PubMed
    Score: 0.048
  36. Screening for adverse events. J Eval Clin Pract. 1999 Feb; 5(1):23-32.
    View in: PubMed
    Score: 0.038
  37. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv. 1995 Oct; 21(10):541-8.
    View in: PubMed
    Score: 0.031
  38. Computerized physician order entry with clinical decision support in the long-term care setting: insights from the Baycrest Centre for Geriatric Care. J Am Geriatr Soc. 2005 Oct; 53(10):1780-9.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.